Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Jun 02, 2022 5:32pm
245 Views
Post# 34727827

RE:RE:RE:Hopefully on Monday, Dr Witkowski can update his Abstract

RE:RE:RE:Hopefully on Monday, Dr Witkowski can update his AbstractI agree. I guess this is the problem when you are compensated handsomely upfront without having any targets. Pockets are full so why bother working hard. 




Also, just because they said they have been "talking" to institutions doesn't mean they have committed to anything. This is the thing people who tow the company rope don't understand. Management constantly make statements like "we're talking to", "we are working on" which doesn't mean anything but people walk away expecting big things.




Best thing for an institution to do to build a position would  be to short the snot out of the stock and freak out the retailers and take their shares. In my opinion, no institutions are going to just buy stock at market and drive the price up unless they get a finanacing at a certain $ amount. Since we are cashed up and supposedly Spill doesn't want to dilute (but we've heard that  before), my guess is they will not bother with this or maybe take very small positions as any big drives the share price up significantly. The mexican standoff continues for now.

<< Previous
Bullboard Posts
Next >>